A prospective, longitudinal, case-control study to evaluate the neurodevelopment of children from birth to adolescence exposed to COVID-19 in utero.
COVID-19
Neurodevelopment
Pregnancy
Prospective
SARS-CoV2
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
30 01 2023
30 01 2023
Historique:
received:
13
04
2022
accepted:
19
01
2023
entrez:
31
1
2023
pubmed:
1
2
2023
medline:
2
2
2023
Statut:
epublish
Résumé
The Coronavirus disease (COVID-19) pandemic has created unprecedented acute global health challenges. However, it also presents a set of unquantified and poorly understood risks in the medium to long term, specifically, risks to children whose mothers were infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during pregnancy. Infections during pregnancy can increase the risk of atypical neurodevelopment in the offspring, but the long-term neurodevelopmental impact of in utero COVID-19 exposure is unknown. Prospective, longitudinal studies are needed to evaluate children exposed in utero to SARS-CoV2 to define this risk. We have designed a prospective, case-controlled study to investigate the long-term impacts of SARS-CoV2 exposure on children exposed in utero. Women infected with SARS-CoV-2 during pregnancy will be recruited from Monash Health, the Royal Women's Hospital and Western Health (Melbourne, Australia) and Londrina Municipal Maternity Hospital Lucilla Ballalai and PUCPR Medical Clinical (Londrina, Brazil). A control group in a 2:1 ratio (2 non-exposed: 1 exposed mother infant dyad) comprising women who gave birth in the same month of delivery, are of similar age but did not contract SARS-CoV-2 during their pregnancy will also be recruited. We aim to recruit 170 exposed and 340 non-exposed mother-infant dyads. Clinical and socio-demographic data will be collected directly from the mother and medical records. Biospecimens and clinical and epidemiological data will be collected from the mothers and offspring at multiple time points from birth through to 15 years of age using standardised sample collection, and neurological and behavioural measures. The mapped neurodevelopmental trajectories and comparisons between SARS-CoV-2 exposed and control children will indicate the potential for an increase in atypical neurodevelopment. This has significant implications for strategic planning in the mental health and paediatrics sectors and long-term monitoring of children globally.
Sections du résumé
BACKGROUND
The Coronavirus disease (COVID-19) pandemic has created unprecedented acute global health challenges. However, it also presents a set of unquantified and poorly understood risks in the medium to long term, specifically, risks to children whose mothers were infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during pregnancy. Infections during pregnancy can increase the risk of atypical neurodevelopment in the offspring, but the long-term neurodevelopmental impact of in utero COVID-19 exposure is unknown. Prospective, longitudinal studies are needed to evaluate children exposed in utero to SARS-CoV2 to define this risk.
METHODS
We have designed a prospective, case-controlled study to investigate the long-term impacts of SARS-CoV2 exposure on children exposed in utero. Women infected with SARS-CoV-2 during pregnancy will be recruited from Monash Health, the Royal Women's Hospital and Western Health (Melbourne, Australia) and Londrina Municipal Maternity Hospital Lucilla Ballalai and PUCPR Medical Clinical (Londrina, Brazil). A control group in a 2:1 ratio (2 non-exposed: 1 exposed mother infant dyad) comprising women who gave birth in the same month of delivery, are of similar age but did not contract SARS-CoV-2 during their pregnancy will also be recruited. We aim to recruit 170 exposed and 340 non-exposed mother-infant dyads. Clinical and socio-demographic data will be collected directly from the mother and medical records. Biospecimens and clinical and epidemiological data will be collected from the mothers and offspring at multiple time points from birth through to 15 years of age using standardised sample collection, and neurological and behavioural measures.
DISCUSSION
The mapped neurodevelopmental trajectories and comparisons between SARS-CoV-2 exposed and control children will indicate the potential for an increase in atypical neurodevelopment. This has significant implications for strategic planning in the mental health and paediatrics sectors and long-term monitoring of children globally.
Identifiants
pubmed: 36717903
doi: 10.1186/s12887-023-03858-w
pii: 10.1186/s12887-023-03858-w
pmc: PMC9885906
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
48Informations de copyright
© 2023. The Author(s).
Références
J Pediatr. 1998 Sep;133(3):406-16
pubmed: 9738726
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 5;42:1-4
pubmed: 23085074
Prenat Diagn. 2020 Dec;40(13):1759-1761
pubmed: 32304114
Arch Pediatr Adolesc Med. 2010 May;164(5):470-7
pubmed: 20439799
J Clin Invest. 2020 Sep 1;130(9):4947-4953
pubmed: 32573498
J Infect Public Health. 2021 Jul;14(7):863-875
pubmed: 34118736
JAMA. 2020 May 12;323(18):1846-1848
pubmed: 32215581
Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2441-2445
pubmed: 32661809
Prog Neurobiol. 2010 Mar;90(3):285-326
pubmed: 19857543
J Paediatr Child Health. 2016 Jan;52(1):54-9
pubmed: 26289780
JAMA Pediatr. 2017 Sep 1;171(9):897-907
pubmed: 28715518
J Autism Dev Disord. 2000 Jun;30(3):237-43
pubmed: 11055459
J Autism Dev Disord. 2015 Dec;45(12):4015-25
pubmed: 24366406
J Autism Dev Disord. 2010 Dec;40(12):1423-30
pubmed: 20414802
Arch Gen Psychiatry. 1988 Feb;45(2):189-92
pubmed: 3337616
Behav Brain Res. 2009 Dec 7;204(2):313-21
pubmed: 19136031
Am J Perinatol. 2020 Jun;37(8):861-865
pubmed: 32305046
JAMA. 2020 May 12;323(18):1848-1849
pubmed: 32215589
Am J Obstet Gynecol MFM. 2020 Aug;2(3):100145
pubmed: 32427221
PLoS One. 2021 Apr 22;16(4):e0250196
pubmed: 33886645
Br J Psychiatry. 1987 Jun;150:782-6
pubmed: 3651732
Arch Gen Psychiatry. 2004 Aug;61(8):774-80
pubmed: 15289276
Dev Neurobiol. 2012 Oct;72(10):1272-6
pubmed: 22488761
Child Neuropsychol. 2000 Sep;6(3):235-8
pubmed: 11419452